{"id":"W4321850279","doi":"10.1177/20420986221146418","title":"Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Communications Research Centre Canada","funders":"Spark Therapeutics; Hemophilia Federation of America; HEMA Biologics; National Hemophilia Foundation; BioMarin Pharmaceutical; CSL Behring; Novo Nordisk; Sanofi; Pfizer; Roche; Bayer; Genentech; Britannia Pharmaceuticals; Grifols; Octapharma","keywords":"Medicine; Pharmacovigilance; Pharmacology; Intensive care medicine; Adverse effect; Family medicine; Pediatrics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08414061,0.00145611,0.003131591,0.003126088,0.003296639,0.01294239,0.003455924,0.01027455,0.00504595],"category_scores_gemma":[0.1084713,0.0008911336,0.003067516,0.003510955,0.003922333,0.01433826,0.0112843,0.02288288,0.001725397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007644814,"about_ca_system_score_gemma":0.04431395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006123585,"about_ca_topic_score_gemma":0.008261074,"domain_scores_codex":[0.9228466,0.05249302,0.005598558,0.002588796,0.01331555,0.00315755],"domain_scores_gemma":[0.8167473,0.106072,0.0110697,0.004515448,0.0417846,0.01981096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002267998,0.0001840756,0.003670916,0.01739927,0.000608632,0.001145717,0.008502924,0.0008416675,0.001040356,0.04284243,0.3441944,0.5793428],"study_design_scores_gemma":[0.0002281903,0.0003872383,0.004412416,0.03898817,0.0006474948,0.002323135,0.009674939,0.001295166,0.0009167482,0.0501081,0.8907493,0.0002692023],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001588258,0.1954137,0.01317505,0.7754363,0.007058579,0.000281462,0.0001448714,0.0004968614,0.00640498],"genre_scores_gemma":[0.06212789,0.364876,0.06169237,0.4898806,0.01602152,0.000866938,0.0006940784,0.0002473985,0.003593273],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.08414061,"threshold_uncertainty_score":0.4449834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1332966043249416,"score_gpt":0.4440379314710621,"score_spread":0.3107413271461205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}